Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synaptic Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Synaptic Medical

Synaptic Medical

Series G

Synaptic Medical: Innovating cost-effective cardiac care technologies since 2005.

HQ
Lake Forest, CA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Founded in 2005 in Minnesota, Synaptic Medical is a medical device company dedicated to developing and commercializing innovative products for the treatment of cardiac arrhythmias and other cardiovascular diseases. Their mission is to create unique, cost-effective, and clinically advanced technologies that enable physicians to optimize and expand treatment options. The company's core focus is on delivering high-quality medical devices that improve patient outcomes and enhance the prognosis of arrhythmia and related ailments.

Synaptic Medical has attracted notable investors and industry experts who support its vision of advancing cardiac care. The company has achieved significant milestones in product development and clinical trials, positioning itself as a leader in the medical device industry. Its impact is evident in the improved treatment options available to physicians and the enhanced quality of life for patients suffering from cardiovascular diseases.

Synaptic Medical - Quick Facts

When was Synaptic Medical founded?

Synaptic Medical was founded in 2005.

Where is Synaptic Medical's headquarters located?

Synaptic Medical's headquarters is located in Lake Forest, CA, US.

When was Synaptic Medical's last funding round?

Synaptic Medical's most recent funding round was for $60M (USD) in March 2021.

How much has Synaptic Medical raised to-date?

As of Mar 25, 2021, Synaptic Medical has raised a total of $60M (USD).

How many employees does Synaptic Medical have?

Synaptic Medical has 350 employees as of Feb 5, 2024.

Synaptic Medical - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Medical
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified